BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine

Reuters
08 Apr
BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine

April 8 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:

  • SIXTY DEGREES PHARMACEUTICALS ANNOUNCES PATENT LICENSE AGREEMENT TO ADVANCE DEVELOPMENT OF TAFENOQUINE FOR BABESIOSIS TREATMENT AND PREVENTION WITH YALE SCHOOL OF MEDICINE AND YALE SCHOOL OF PUBLIC HEALTH

Source text: ID:nGNX51JxNm

Further company coverage: SXTP.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10